Ligand Pharmaceuticals Inc
F:LGDN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Ligand Pharmaceuticals Inc
F:LGDN
|
US |
|
C
|
Colliers International Group Inc
NASDAQ:CIGI
|
CA |
|
R
|
Ralph Lauren Corp
XBER:PRL
|
US |
|
C
|
Comtech Telecommunications Corp
F:CC6
|
US |
|
P
|
PTC Inc
DUS:PMTA
|
US |
|
C
|
Comcast Corp
XHAM:CTP2
|
US |
|
Applovin Corp
F:6RV
|
US |
|
Cerebras Systems Inc.
NASDAQ:CBRS
|
US |
|
A
|
AXA SA
XMUN:AXA
|
FR |
|
M
|
Mosaic Co
XMUN:02M
|
US |
|
ASML Holding NV
AEX:ASML
|
NL |
|
H
|
Hasbro Inc
XBER:HAS
|
US |
|
H
|
Humana Inc
SWB:HUM
|
US |
|
Bank of Communications Co Ltd
OTC:BKFCF
|
CN |
|
O
|
Osaka Gas Co Ltd
OTC:OSGSY
|
JP |
|
T
|
Tetra Tech Inc
F:TT6
|
US |
|
Mister Car Wash Inc
NYSE:MCW
|
US |
|
C
|
China Merchants Port Holdings Co Ltd
XMUN:CPM
|
HK |
|
H
|
Heidelberg Materials AG
MIL:1HEI
|
DE |
|
InspireMD Inc
F:II2
|
IL |
|
F
|
Fujitsu General Ltd
SWB:29F
|
JP |
|
W
|
Wilmar International Ltd
XMUN:RTHA
|
SG |
|
O
|
Orlen SA
PSE:PKN
|
PL |
|
C
|
Chipotle Mexican Grill Inc
XMUN:C9F
|
US |
Wall St Price Targets
LGDN Price Targets Summary
Ligand Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for LGDN is 140.41 EUR with a low forecast of 123.92 EUR and a high forecast of 172.12 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LGDN's stock price target?
Price Target
140.41
EUR
According to Wall Street analysts, the average 1-year price target for LGDN is 140.41 EUR with a low forecast of 123.92 EUR and a high forecast of 172.12 EUR.
What is the Revenue forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
16%
Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 16%.
What is the Gross Profit forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
17%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 7 years is 17%.
What is the Operating Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
34%
Over the last 14 years, the compound annual growth rate for Operating Income has been 26%. The projected CAGR for the next 8 years is 34%.
What is the Pre-Tax Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 24%.
What is the Net Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
26%
Over the last 14 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 7 years is 26%.
